# Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects

> **NCT01002261** · — · COMPLETED · sponsor: **Aarhus University Hospital** · enrollment: 16 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01002261
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002261, "Hepatic Metabolism of Galactose and the Galactose Analog FDGal in Patients With Liver Disease and Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01002261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*